At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,049 enrolled
Drug / intervention
Intense Education Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
COOrdinating CaRDIology CliNics RAndomized Trial of Interventions to Improve OutcomEs (COORDINATE) - Diabetes
In Brief
A clinical study evaluating Intense Education Intervention for Diabetes Mellitus, Type 2 and Cardiovascular Diseases. Completed, enrolled 1,049 participants across 44 sites.
Detailed Summary
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Cardiovascular Diseases
CountriesUnited States
CollaboratorsBoehringer Ingelheim, Eli Lilly and Company
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedMay 2019
Enrollment StartJul 2019
Primary CompletionDec 2022
TodayJul 2026
First PostedMay 3, 2019
Enrollment StartJul 25, 2019
Primary CompletionDec 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 7.2 years ago
Interventions
Intense Education Interventionother
Clinics provided with existing clinical care guidelines as well as a multifaceted educational intervention to support development of an integrated, multi-disciplinary care pathway for patients with T2DM and CVD.